Home›People›Adele Oliva
Adele Oliva

Adele Oliva

Partner and Co-Founder, 1315 Capital, director at Onkos Surgical.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Aug 7, 2026·Suggest an edit

About Adele Oliva

Adele Oliva is a partner and co-founder, 1315 capital, director at Onkos Surgical.

Adele Oliva reports to the SEC as a director or major shareholder of 1 public company: TELA Bio (TELA).

Adele Oliva first appears on SEC filings in 2017.

Experience

This experience comes from SEC filings. The years are when the filings name Adele Oliva in the role, so the role may have started earlier or lasted longer.

Onkos Surgical, Inc.
Partner and Co-Founder, 1315 Capital, director
2017 – 2026 · Parsippany, NJ
Orthopedic implants and surgical planning tools for surgeons treating bone tumors and complex conditions.
TELA Bio, Inc.
Director and 10% owner
2019 – 2020 · Public company (TELA)

Key Colleagues at Startups

The people Adele Oliva works with at each company, as listed on that company's latest Form D.

Onkos Surgical, Inc. · Form D/A, Aug 7, 2026
Antony Koblish
Antony Koblish
CEO and President, TELA Bio, director
Bradly Tyler
Bradly Tyler
Senior Vice President, Finance and Administration
Patrick Treacy
Patrick Treacy
Founder and Chief Executive Officer, director
Paul Touhey
Paul Touhey
Director

Sources

  1. SECOnkos Surgical, Inc. Form D/A, filed Aug 7, 2026
  2. SECForms 3, 4 and 5 filed by Adele Oliva (SEC filer 1339379)